LexDanaLexDanabeta
Inventor

KYLE E. PARCELLA

Inventor
US

Overview

3→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,594,276Inhibitors of human immunodeficiency virus replication202611,541,055Inhibitors of human immunodeficiency virus replication202311,505,5434-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to VIIV HEALTHCARE UK NO 5 LTD (3)· patent assignee history
2022–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VIIV HEALTHCARE UK NO 5 LTD32022–2026
Locations
LocationPatentsSpan
US32022–2026